Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 8/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.42 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28049798 | 0.92 | MMP3 (0.50) | ESR1ESR2MEN1KMT2AMAPT | |
| SCHEMBL6292615 | 0.92 | MMP3 (0.50) | ESR1ESR2MEN1KMT2AMAPT | |
| SCHEMBL28865295 | 0.91 | MMP3 (0.48) | ESR1ESR2MEN1KMT2AMAPT | |
| SCHEMBL9582303 | 0.91 | RPS6KA3 (0.43) | ESR1ESR2SENP1MEN1KMT2A | |
| SCHEMBL8179946 | 0.91 | MMP3 (0.48) | ESR1ESR2MEN1KMT2AMAPT | |
| SCHEMBL28436561 | 0.91 | MMP3 (0.48) | ESR1ESR2MEN1KMT2AMAPT | |
| SCHEMBL27864432 | 0.91 | THRB (0.46) | ESR1ESR2SENP1MEN1KMT2A | |
| SCHEMBL22463700 | 0.86 | CA2 (0.52) | ESR2MEN1KMT2AMAPTRAB9A | |
| SCHEMBL4410281 | 0.86 | ESR2 (0.56) | ESR1ESR2MEN1KMT2AMAPT | |
| SCHEMBL7258220 | 0.85 | LMNA (0.53) | SENP1SMN1; SMN2ALDH1A1HSD17B10POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | JIANGNAN UNIVERSITY (CN) | 2026-03-03 | — | — | US | claimed |
| US-20220340423-A1 | Photothermal Catalytic Method for Production of Hydrogen Peroxide without Sacrificial Reagents on Basis of Porphyrin-based Supermolecule | JIANGNAN UNIVERSITY (CN) | 2022-10-27 | — | — | US | claimed |
| EP-1600766-B1 | ACTIVE OXYGEN SPECIES MEASURING DEVICE | YUASA MAKOTO (JP) | 2019-06-26 | — | — | EP | claimed |
| US-9867800-B2 | Method of quenching singlet and triplet excited states of pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds have electron withdrawing groups, to reduce generation of reactive oxygen species, particularly singlet oxygen | HALLSTAR INNOVATIONS CORP. (US) | 2018-01-16 | — | — | US | claimed |
| US-20180000753-A1 | EUTECTIC SOLVENTS AND USES THEREOF | UNIVERSITY OF OSLO (NO) | 2018-01-04 | — | — | US | claimed |
| WO-2016108083-A1 | EUTECTIC SOLVENTS AND USES THEREOF | UNIVERSITY OF OSLO (NO) | 2016-07-07 | — | — | WO | claimed |
| US-20150164852-A1 | METHOD OF QUENCHING SINGLET AND TRIPLET EXCITED STATES OF PIGMENTS, SUCH AS PORPHYRIN COMPOUNDS, PARTICULARLY PROTOPORPHYRIN IX, WITH CONJUGATED FUSED TRICYCLIC COMPOUNDS HAVE ELECTRON WITHDRAWING GROUPS, TO REDUCE GENERATION OF REACTIVE OXYGEN SPECIES, PARTICULARLY SINGLET OXYGEN | HALLSTAR INNOVATIONS CORP. (US) | 2015-06-18 | — | — | US | claimed |
| WO-2014025370-A1 | TRICYCLIC ENERGY QUENCHER COMPOUNDS FOR REDUCING SINGLET OXYGEN GENERATION | HALLSTAR INNOVATIONS CORP. (US) | 2014-02-13 | — | — | WO | claimed |
| US-8298387-B2 | Reactive oxygen species measuring device | YUASA MAKOTO (JP) | 2012-10-30 | — | — | US | claimed |
| US-20060289313-A1 | Reactive oxygen species measuring device | YUASA MAKOTO | 2006-12-28 | — | — | US | claimed |
| EP-1600766-A1 | ACTIVE OXYGEN SPECIES MEASURING DEVICE | Yuasa, Makoto (JP) | 2005-11-30 | — | — | EP | claimed |
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | JIANGNAN UNIVERSITY (CN) | 2026-03-03 | — | — | US | disclosed |
| WO-2025047802-A1 | JUNCTION PHOTOCATALYST | 花王株式会社 | 2025-03-06 | — | — | WO | disclosed |
| US-12071498-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2024-08-27 | — | — | US | disclosed |
| US-20240115508-A1 | NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS | THE JOHNS HOPKINS UNIVERSITY | 2024-04-11 | — | — | US | disclosed |
| EP-0336879-A1 | Meso-tetraphenylporphyrin complex compounds,process for their preparation and pharmaceuticals containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-10-11 | — | — | EP | disclosed |
| US-4837221-A | ADMINISTERING PORPHYRIN DERIVATIVE TO LOCATE TUMOR, ILLUMINATING WITH LIGHT | EFAMOL LTD. (GB) | 1989-06-06 | — | — | US | disclosed |
| EP-0186962-B1 | PORPHYRINS AND CANCER TREATMENT | EFAMOL LIMITED (GB) | 1989-04-12 | — | — | EP | disclosed |
| EP-0214839-A2 | Improvements in relation to drug treatments | EFAMOL HOLDINGS PLC (GB) | 1987-03-18 | — | — | EP | disclosed |
| EP-0186962-A1 | Porphyrins and cancer treatment | EFAMOL LIMITED (GB) | 1986-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | TPO, PPOX, THPO | ESR1 4540/4885ESR2 4527/4885SENP1 327/4885 |
| US-20240115508-A1 | NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS | MUC1, SLC35A1, EPCAM | ESR1 2315/4885ESR2 2773/4885SENP1 4318/4885 |
| US-20150164852-A1 | METHOD OF QUENCHING SINGLET AND TRIPLET EXCITED STATES OF PIGMENTS, SUCH AS PORPHYRIN COMPOUNDS, PARTICULARLY PROTOPORPHYRIN IX, WITH CONJUGATED FUSED TRICYCLIC COMPOUNDS HAVE ELECTRON WITHDRAWING GROUPS, TO REDUCE GENERATION OF REACTIVE OXYGEN SPECIES, PARTICULARLY SINGLET OXYGEN | NOX3, CBR3, CCR3 | ESR1 2195/4885ESR2 1456/4885SENP1 4656/4885 |
| US-20180000753-A1 | EUTECTIC SOLVENTS AND USES THEREOF | UROD, DUS2, ALAD | ESR1 503/4885ESR2 671/4885SENP1 2115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.